AAAAAA
Results:
1-23
|
Results: 23
Authors:
JOHNSTONE SA
WEST MHP
FRIEDLAND D
GELMON K
BALLY MB
Citation: Sa. Johnstone et al., THE CYTOTOXICITY OF CATIONIC-PEPTIDES IS EQUIVALENT WHEN TESTED IN-VITRO AGAINST WILD-TYPE AND MDR TUMOR-CELL LINES, Annals of oncology, 9, 1998, pp. 138-138
Authors:
GELMON K
TOMIAK E
TOLCHER T
BLACKSTEIN M
ZEE B
BATIST G
IGLESIAS J
FISHER B
EISENHAUER E
Citation: K. Gelmon et al., RANDOMIZED TRIAL OF HIGH-DOSE PACLITAXEL (TAXOL, T) PLUS MINUS AMIFOSTINE (A) IN METASTATIC BREAST-CANCER (MBC) - A STUDY OF THE NCIC CLINICAL-TRIALS GROUP (CTG)/, Annals of oncology, 9, 1998, pp. 371-371
Authors:
LATREILLE J
GELMON K
EISENHAUER E
TOLCHER A
FISHER B
VERNILLET L
DAIGNEAULT L
HOSTETLERYANOWITZ C
LEBECQ A
BESENVAL M
Citation: J. Latreille et al., PHASE-I TRIAL OF THE NEW TAXOID RPR 109881A IN A DAY 1 AND 8 INTRAVENOUS (IV) SCHEDULE EVERY 3 WEEKS - AN NCI CANADA CLINICAL-TRIALS GROUP-STUDY, Annals of oncology, 9, 1998, pp. 382-382
Authors:
LEBECQ A
DIERAS V
MARTY M
SESSA C
PAZDUR R
GELMON K
LATREILLE J
EISENHAUER E
BESENVAL M
RIVA A
DURRLEMAN S
Citation: A. Lebecq et al., PRELIMINARY EVALUATION OF THE MODIFIED CONTINUAL REASSESSMENT METHOD (MCRM) IN 4 PHASE-I STUDIES WITH RPR109881A, Annals of oncology, 9, 1998, pp. 488-488
Authors:
GINSBURG AD
LEVINE MN
BOWMAN DM
OLIVOTTO IA
FIELDS LA
LITTLE CD
CANTIN J
MCGREGOR M
GOLDHIRSCH A
BRAMWELL V
GELMON K
BRYCE C
ALLAN S
NORRIS B
LATREILLE J
PATERSON ADH
TOMIAK E
TREMBLAY G
BAIRD R
BECKER P
BUTTS C
DANCEY JT
GOEL R
KVERN B
MILNE C
NAROD S
NOLAN E
THURLOW WH
WONG R
Citation: Ad. Ginsburg et al., ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 43-51
Authors:
SHEPHERD FA
BEAULIEU R
GELMON K
THUOT CA
SAWKA C
READ S
SINGER J
Citation: Fa. Shepherd et al., PROSPECTIVE RANDOMIZED TRIAL OF 2 DOSE LEVELS OF INTERFERON-ALPHA WITH ZIDOVUDINE FOR THE TREATMENT OF KAPOSIS-SARCOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A CANADIAN HIV CLINICAL-TRIALS NETWORK STUDY, Journal of clinical oncology, 16(5), 1998, pp. 1736-1742
Authors:
WESTEEL V
MURRAY N
GELMON K
SHAH A
SHEEHAN F
MCKENZIE M
WONG F
MORRIS J
GRAFTON C
TSANG V
GODDARD K
MURPHY K
PARSONS C
AMY R
PAGE R
Citation: V. Westeel et al., NEW COMBINATION OF THE OLD DRUGS FOR ELDERLY PATIENTS WITH SMALL-CELLLUNG-CANCER - A PHASE-II STUDY OF THE PAVE REGIMEN, Journal of clinical oncology, 16(5), 1998, pp. 1940-1947
Authors:
MURRAY N
GRAFTON C
SHAH A
GELMON K
KOSTASHUK E
BROWN E
COPPIN C
COLDMAN A
PAGE R
Citation: N. Murray et al., ABBREVIATED TREATMENT FOR ELDERLY, INFIRM, OR NONCOMPLIANT PATIENTS WITH LIMITED-STAGE SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3323-3328
Authors:
WEBB MS
LOGAN P
KANTER PM
STONGE G
GELMON K
HARASYM T
MAYER LD
BALLY MB
Citation: Ms. Webb et al., PRECLINICAL PHARMACOLOGY, TOXICOLOGY AND EFFICACY OF SPHINGOMYELIN CHOLESTEROL LIPOSOMAL VINCRISTINE FOR THERAPEUTIC TREATMENT OF CANCER/, Cancer chemotherapy and pharmacology, 42(6), 1998, pp. 461-470
Authors:
EMBREE L
GELMON K
TOLCHER A
HUDON N
HEGGIE J
DEDHAR C
LOGAN P
BALLY MB
MAYER LD
Citation: L. Embree et al., PHARMACOKINETIC BEHAVIOR OF VINCRISTINE SULFATE FOLLOWING ADMINISTRATION OF VINCRISTINE SULFATE LIPOSOME INJECTION, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 347-352
Authors:
MUNK PL
POON PY
OCONNELL JX
JANZEN D
COUPLAND D
KWONG JS
GELMON K
WORSLEY D
Citation: Pl. Munk et al., OSTEOBLASTIC METASTASES FROM BREAST-CARCINOMA WITH FALSE-NEGATIVE BONE-SCAN, Skeletal radiology, 26(7), 1997, pp. 434-437
Authors:
KIRKBRIDE P
GELMON K
EISENHAUER E
FISHER B
DULUDE H
Citation: P. Kirkbride et al., A PHASE I II STUDY OF PACLITAXEL (TAXOL(R)) AND CONCURRENT RADIOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER/, International journal of radiation oncology, biology, physics, 39(5), 1997, pp. 1107-1111
Authors:
GOSS PE
FINE S
GELMON K
RUDINSKAS L
OTTAWAY J
MYLES J
JAMES K
PAUL K
RODGERS A
PRITCHARD KI
Citation: Pe. Goss et al., PHASE-I STUDIES OF FLUOROURACIL, DOXORUBICIN AND VINORELBINE WITHOUT (FAN) AND WITH (SUPERFAN) FOLINIC ACID IN PATIENTS WITH ADVANCED BREAST-CANCER, Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 53-60
Authors:
BEBB G
GLICKMAN B
GELMON K
GATTI R
Citation: G. Bebb et al., AT RISK FOR BREAST-CANCER, Lancet, 349(9068), 1997, pp. 1784-1785
Authors:
HUCKELL C
LASKIN J
GELMON K
Citation: C. Huckell et al., PREMENOPAUSAL BREAST-CANCER AFTER IN-UTERO EXPOSURE TO STILBESTROL, Lancet, 348(9023), 1996, pp. 331-331
Authors:
PERETZ T
SULKES A
CHOLLET P
GELMON K
PARIDAENS R
GORBONUVA V
CATIMEL G
KUHNLE H
HUININK WTB
KHAYAT D
DITTRICH C
KLAASSEN U
BERGH J
WILKING N
NABHOLTZ JM
CALABRESI F
TUBIANAHULIN M
CHAZARD M
GALLANT G
DIERGARTEN K
WESTBERG R
BOGAERT J
RENARD J
WEIL C
Citation: T. Peretz et al., A MULTICENTER, RANDOMIZED STUDY OF 2 SCHEDULES OF PACLITAXEL (PTX) INPATIENTS WITH ADVANCED BREAST-CANCER (ABC), European journal of cancer, 31A, 1995, pp. 345-345
Authors:
DEJONG G
GELMON K
BALLY M
GOLDIE J
MAYER L
Citation: G. Dejong et al., MODULATION OF DOXORUBICIN RESISTANCE IN P388 ADR CELLS BY RO44-5912, A TIAPAMIL DERIVATIVE/, Anticancer research, 15(3), 1995, pp. 911-916
Authors:
ARNOLD A
AYOUB J
DOUGLAS L
HOOGENDOORN P
SKINGLEY L
GELMON K
HIRSH V
EISENHAUER E
Citation: A. Arnold et al., PHASE-II TRIAL OF 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA IN NON-SMALL-CELL LUNG-CANCER, Journal of the National Cancer Institute, 86(4), 1994, pp. 306-309
Authors:
SHENKIER T
GELMON K
Citation: T. Shenkier et K. Gelmon, PACLITAXEL AND RADIATION-RECALL DERMATITIS, Journal of clinical oncology, 12(2), 1994, pp. 439-439
Authors:
GELMON K
Citation: K. Gelmon, THE TAXOIDS - PACLITAXEL AND DOCETAXEL, Lancet, 344(8932), 1994, pp. 1267-1272
Authors:
GELMON K
Citation: K. Gelmon, THE TAXOIDS - PACLITAXEL AND DOCETAXEL, Lancet, 344(8932), 1994, pp. 1267-1272
Authors:
SELIGMANN M
WARRELL DA
ABOULKER JP
CARBON C
DARBYSHIRE JH
DORMONT J
ESCHWEGE E
GIRLING DJ
JAMES DR
LEVY JP
PETO TEA
SCHWARZ D
STONE AB
WELLER IVD
WITHNALL R
GELMON K
LAFON E
SWART AM
ABER VR
BABIKER AG
LHORO S
NUNN AJ
VRAY M
Citation: M. Seligmann et al., CONCORDE - MRC ANRS RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF IMMEDIATE AND DEFERRED ZIDOVUDINE IN SYMPTOM-FREE HIV-INFECTION/, Lancet, 343(8902), 1994, pp. 871-881
Authors:
GREGG RWC
KAIZER L
FINE S
GELMON K
WIELGOSZ G
EISENHAUER E
Citation: Rwc. Gregg et al., A PHASE-II TRIAL OF DUP-937 (TELOXANTRONE) IN NON-SMALL-CELL LUNG-CANCER - A STUDY OF THE NCIC CLINICAL-TRIALS GROUP, Annals of oncology, 4(8), 1993, pp. 693-694
Risultati:
1-23
|